# Amylyx Pharmaceuticals, Inc. — Form D/A

Amylyx Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-12-31. The offering totals $15.0M, of which $937K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-12-31
- Form: D/A
- Accession: 0001658551-19-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $937K
- Remaining: $14.1M
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2019-12-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-356768

## Issuer

- Name: Amylyx Pharmaceuticals, Inc.
- CIK: 0001658551
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 43 THORNDIKE STREET, CAMBRIDGE, MA, 02141
- Phone: 617-683-0917

## Officers, directors & promoters (13)

| Name | Role | Location |
| --- | --- | --- |
| Joshua Cohen | Director | Coral Gables, FL |
| Joshua Cohen | Executive Officer | Coral Gables, FL |
| Peter Finn | Executive Officer | Watertown, MA |
| Isaac Cheng | Director | Portland, ME |
| Stephen Chubb | Director | BOSTON, MA |
| Justin Klee | Director | Cambridge, MA |
| Justin Klee | Executive Officer | Cambridge, MA |
| George Milne | Director | Cambridge, MA |
| Walter Gilbert | Director | Cambridge, MA |
| Felix Von Coerper | Director | Cambridge, MA |
| Stephen D Chubb | Director | Cambridge, MA |
| George M Milne, PH.D. | Director | Cambridge, MA |
| Peter B Finn | Executive Officer | Boston, MA |

## Other filings by this issuer (9)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-07-01](https://search.stillhousedata.com/formd/0001658551-20-000002) | D | $30.0M | $30.0M |
| [2020-01-28](https://search.stillhousedata.com/formd/0001658551-20-000001) | D/A | $20.0M | $14.8M |
| [2019-12-31](https://search.stillhousedata.com/formd/0001658551-19-000001) | D | $15.0M | $937K |
| [2018-11-20](https://search.stillhousedata.com/formd/0001658551-18-000001) | D | $13.0M | $13.0M |
| [2017-08-04](https://search.stillhousedata.com/formd/0001658551-17-000001) | D | $2.3M | $1.8M |
| [2016-08-22](https://search.stillhousedata.com/formd/0001658551-16-000003) | D | $5.0M | $4.1M |
| [2016-08-22](https://search.stillhousedata.com/formd/0001658551-16-000004) | D/A | $5.0M | $4.1M |
| [2015-11-20](https://search.stillhousedata.com/formd/0001658551-15-000002) | D/A | $1.6M | $1.4M |
| [2015-11-17](https://search.stillhousedata.com/formd/0001658551-15-000001) | D | $1.6M | $1.4M |

## More

- [CIK 1658551 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1658551&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001658551-19-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.